In addition, PD-1 blockage on DCs, administered in a breast tumor-bearing mouse model, that were subsequently systemically treated with anti-PD-1 mAb reduced tumor growth and increased survival compared to untreated mice.104. The gene discussed is PDCD1; the disease is breast neoplasm.